Advertisement

Lead-exposure of neonatal rats through maternal milk

A confounded model
  • Augusta A. Mylroie
  • Cynthia Tucker
  • Linda Rosselli-Austin
Article

Abstract

Lead-exposed neonatal rats are frequently used as a model for plumbism in children. In most studies,PPb is administered to the dam, and it is assumed that the pups are exposed to Pb primarily from the dam's milk. Rat pups, however, are coprophagic and begin to consume the maternal feces in their second postnatal week. This experiment was designed to determine whether the maternal feces are a significant source of Pb in pups exposed via the lactating dam. Dams were administered Pb as lead acetate (PbAc), either through their drinking water (500 ppm PbAc) or through twice daily intubations (3 mg PbAc/Kg body wt) from postpartum d 1 (P1) to P21 (P0=day of birth). Control dams were administered deionized water. The dams were housed with their litters in stainless-steel hanging cages with wire-screened bottoms. Litters of exposed and control dams treated through their drinking water had access to either Pb-containing or Pb-free maternal fecal matter for 2 h/d during the late lactation period. Half of the litters from intubated dams had continuous access to maternal feces throughout the lactation period, whereas access was curtailed at P14 in the other litters. Lead content of the feces from Pb-exposed dams ranged from 1000 to 5000 μg Pb/g wet wt. At P21, Pb concentrations were 2–4 times higher in blood, brain, bone, and liver of pups that had access to Pb-contaminated feces than in pups that were exposed to Pb primarily through the mother's milk. When estimating exposure levels in pups receiving Pb through the lactating dam, coprophagy and the high content of Pb in the dam's feces must be taken into consideration.

Index Entries

Lead-exposure neonatal rat lactating dam model of lead-exposure low-level lead exposure rodent models for lead exposure lead toxicity coprophagy toxicology methods 

References

  1. 1.
    A. Pentschew and F. Garro,Acta Neuropathol. (Berlin) 6, 266 (1966).CrossRefGoogle Scholar
  2. 2.
    M. R. Krigman, M. J. Druse, T. D. Traylor, M. H. Wilson, L. R. Newell, and E. L. Hogan,J. Neuropathol. Exp. Neurol. 33, 671 (1974).PubMedGoogle Scholar
  3. 3.
    P. Lampert, F. Garro, and A. Pentschew, inSymposium on Brain Edema, I. Klatzo and F. Seitelberger, eds., Springer, New York, NY, 1967, pp. 207–222.Google Scholar
  4. 4.
    I. A. Michaelson,Toxicol. Appl. Pharmacol. 26, 539 (1973).PubMedCrossRefGoogle Scholar
  5. 5.
    E. K. Silbergeld and A. M. Goldberg,Life Sci. 13, 1275 (1973).CrossRefGoogle Scholar
  6. 6.
    M. R. Hejtmancik, Jr., E. B. Dawson, and B. J. Williams,J. Toxicol. Environ. Health 9, 77 (1982).PubMedGoogle Scholar
  7. 7.
    M. W. Sauerhoff and I. A. Michaelson,Science 187, 1022 (1973).CrossRefGoogle Scholar
  8. 8.
    M. Golter and I. A. Michaelson,Science 187, 359 (1975).PubMedCrossRefGoogle Scholar
  9. 9.
    E. K. Silbergeld and A. M. Goldberg, inLead Toxicity, R. L. Singhal and J. A. Thomas, eds., Urban and Schwarzenberg, Baltimore, MD, 1980, pp. 19–42.Google Scholar
  10. 10.
    I. A. Michaelson and M. W. Sauerhoff,Toxicol. Appl. Pharmacol. 28, 88 (1974).PubMedCrossRefGoogle Scholar
  11. 11.
    L. W. Reiter, G. E. Anderson, J. W. Laskey, and D. F. Cahill,Environ. Health Perspect. 12, 119 (1975).PubMedCrossRefGoogle Scholar
  12. 12.
    J. Kostas, D. J. McFarland, and W. G. Drew,Pharmacology 14, 435 (1976).PubMedGoogle Scholar
  13. 13.
    T. L. Petit and D. P. Alfano,Pharmacol. Biochem. Behav. 11, 165 (1979).PubMedCrossRefGoogle Scholar
  14. 14.
    D. M. Averill and H. L. Needleman, inLow Level Lead Exposure: The Clinical Implications of Current Research, H. L. Needleman, ed., Raven, New York, NY, 1980, pp. 201–210.Google Scholar
  15. 15.
    D. R. Brown,Toxicol. Appl. Pharmacol. 32, 628 (1975).PubMedCrossRefGoogle Scholar
  16. 16.
    D. Krehbiel, G. A. Davis, L. M. LeRoy, and R. E. Bowman,Environ. Health Perspect. 18, 147 (1976).PubMedCrossRefGoogle Scholar
  17. 17.
    D. H. Minsker, N. Moskalski, C. P. Peter, R. T. Robertson, and D. L. Bokelman,Biol. Neonat. 41, 193 (1982).Google Scholar
  18. 18.
    C. Winder, L. L. Garten, and P. D. Lewis,Neuropathol. Appl. Neurobiol. 9, 87 (1983).PubMedCrossRefGoogle Scholar
  19. 19.
    I. A. Michaelson, R. D. Greenland, and W. Roth,Pharmacologist 16, 250 (1974).Google Scholar
  20. 20.
    M. Press,J. Neuropathol. Exp. Neurol. 36, 169 (1977).PubMedGoogle Scholar
  21. 21.
    R. T. Louis-Ferdinand, D. R. Brown, S. F. Fiddler, W. C. Daugherty, and A. W. Klein,Toxicol. Appl. Pharmacol. 43, 351 (1978).PubMedCrossRefGoogle Scholar
  22. 22.
    A. D. Toews, A. Kolber, J. Hayward, M. R. Krigman, and P. Morrell,Brain Res. 147, 131 (1978).PubMedCrossRefGoogle Scholar
  23. 23.
    T. F. Sobotka and M. P. Cook,Am. J. Ment. Defic. 79, 5 (1974).PubMedGoogle Scholar
  24. 24.
    R. J. Bull, P. M. Stanaszek, J. J. O'Neill, and S. D. Lutkenhoff,Environ. Health Perspect. 12, 89 (1975).PubMedCrossRefGoogle Scholar
  25. 25.
    K. Jason and C. Kellogg,Pharmacol. Biochem. Behav. 15, 641 (1981).PubMedCrossRefGoogle Scholar
  26. 26.
    S. R. Overmann,Toxicol. Appl. Pharmacol. 43, 351 (1977).Google Scholar
  27. 27.
    B. G. Gelman and I. A. Michaelson,J. Toxicol. Environ. Health 5, 671 (1979).PubMedCrossRefGoogle Scholar
  28. 28.
    S. R. Overmann, L. Zimmer, and D. E. Woolley,Neurotoxicology 2, 725 (1981).PubMedGoogle Scholar
  29. 29.
    M. C. C. Stephens and G. B. Gerber,Toxicol. Letts. 7, 373 (1981).CrossRefGoogle Scholar
  30. 30.
    R. B. Burright, P. J. Donovick, K. Michels, R. J. Fanelli, and Z. Dolinsky,Pharmacol. Biochem. Behav. 16, 631 (1982).PubMedCrossRefGoogle Scholar
  31. 31.
    J. B. Campbell, D. E. Woolley, V. K. Vijakayan, and S. R. Overmann,Dev. Brain Res. 3, 595 (1982).CrossRefGoogle Scholar
  32. 32.
    Z. Dolinsky, R. G. Burright, and P. J. Donovick,Physiol. Behav. 30, 583. (1983).PubMedCrossRefGoogle Scholar
  33. 33.
    J. M. Lefauconnier, G. Bernard, F. Mellerio, A. Sebille, and E. Cesarini,Experientia 39, 1030 (1983).PubMedCrossRefGoogle Scholar
  34. 34.
    J. C. Kawamoto, V. K. Vijakayan, and D. E. Woolley,Neurobiol. Aging 5, 297 (1984).PubMedCrossRefGoogle Scholar
  35. 35.
    S. M. Sato, J. M. Frazier, and A. M. Goldberg,Exp. Neurol. 85, 620 (1984).PubMedCrossRefGoogle Scholar
  36. 36.
    J. M. Donald, M. G. Cutler, M. R. Moore, and M. Bradley,Neuropharmacology 25, 151 (1986).PubMedCrossRefGoogle Scholar
  37. 37.
    C. Bailey and I. Kitchen,Dev. Brain Res. 22, 75 (1985).CrossRefGoogle Scholar
  38. 38.
    G. P. Cooper, D. A. Fox, W. E. Howell, R. D. Laurie, W. Tsang, and J. P. Lewskowski, inNeurotoxicity of the Visual System, W. H. Merigan and B. Weiss, eds., Raven, New York, NY, 1980, pp. 203–218.Google Scholar
  39. 39.
    S. M. Lasley, R. D. Greenland, D. J. Minnema, and I. A. Michaelson,Neurochem. Res. 9, 1675 (1984).PubMedCrossRefGoogle Scholar
  40. 40.
    M. McCarren and C. V. Eccles,Neurobehav. Toxicol. Teratol. 5, 527 (1983).PubMedGoogle Scholar
  41. 41.
    A. Eden,Nature 145, 628 (1940).CrossRefGoogle Scholar
  42. 42.
    R. H. Barnes, G. Fiala, B. McGehee, and A. Brown,J. Nutr. 63, 489 (1957).PubMedGoogle Scholar
  43. 43.
    S. J. Kilpatrick, T. M. Lee, and H. Moltz,Physiol. Behav. 30, 539 (1983).PubMedCrossRefGoogle Scholar
  44. 44.
    H. Moltz and T. M. Lee,Physiol. Behav. 26, 301 (1981).PubMedCrossRefGoogle Scholar
  45. 45.
    A. Mylroie, L. Moore, and U. Erogbogbo,Toxicol. Appl. Pharmacol. 41, 361 (1977).PubMedCrossRefGoogle Scholar
  46. 46.
    B. J. Winer,Statistical Principles in Experimental Design, 2nd Ed., McGraw-Hill, New York, NY, 1971, pp. 149–260.Google Scholar
  47. 47.
    R. L. Bornschein, D. A. Fox, and I. A. Michaelson,Toxicol. Appl. Pharmacol. 40, 577 (1977).PubMedCrossRefGoogle Scholar
  48. 48.
    K. Kostial, I. Šimonović, and M. Pišonic,Nature (Lond.) 233, 564 (1971).CrossRefGoogle Scholar
  49. 49.
    G. B. Forbes and J. C. Reina,J. Nutr. 102, 647 (1972).PubMedGoogle Scholar
  50. 50.
    H. M. Mykkanen, J. W. T. Dickerson, and M. C. Lancaster,Toxicol. Appl. Pharmacol. 51, 447 (1979).PubMedCrossRefGoogle Scholar
  51. 51.
    H. M. Mykkanen, M. C. Lancaster, and J. W. T. Dickerson,Environ. Res. 28, 147 (1982).PubMedCrossRefGoogle Scholar

Copyright information

© The Humana Press Inc 1987

Authors and Affiliations

  • Augusta A. Mylroie
    • 1
  • Cynthia Tucker
    • 1
  • Linda Rosselli-Austin
    • 2
  1. 1.Department of Physical SciencesChicago State UniversityChicago
  2. 2.Department of Biological SciencesChicago State UniversityChicago

Personalised recommendations